DELIVERY ORDER
Active36C26127F0038
Department of Veterans Affairs › 261-NETWORK CONTRACT OFFICE 21 (36C261)
$175.1K
obligated · signed 2 weeks ago
SEPHIENCE (SEPIAPTERIN)ORAL POWDER
Performance timeline
Start
Nov 3, 2026
End
Mar 3, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Mar 3, 2027
PTC THERAPEUTICS US, INC
Contract 36C26127F0038
UEI
RWWKLJ9LFHU9
Parent Company
PTC THERAPEUTICS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 07
Current Obligation
$175,121
Base + Exercised Options
$175,121
Total Ceiling Value
$175,121
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 06
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
261-NETWORK CONTRACT OFFICE 21 (36C261)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
261-NETWORK CONTRACT OFFICE 21 (36C261)
Office
Contract Vehicle
36F79724D0074
FSSDepartment of Veterans Affairs
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.